Charles D. Kennedy, MD
Charles Kennedy is a Managing Partner of Blue Ox serving on the Investment Committee. Charles is a recognized expert in healthcare delivery, finance and information technology with over 25 years of experience as a C-level executive and board advisor at several leading companies. Prior to Blue Ox, Charles was Chief Population Health Officer for Healthagen, Aetna’s healthcare IT subsidiary. He also launched and served as CEO of Aetna’s Accountable Care Solutions division, growing it to a multi-billion subsidiary of Aetna. Prior to Aetna, Charles was Vice President of Health Information Technology for WellPoint, Co-Founder and Chief Executive Officer of
Charles was also a founding commissioner of the Certification Commission for Health Information Technology (CCHIT) and served a five-year appointment as the health insurance industry representative on the HIT Policy Committee. He also serves on the AHIP Foundation Board of Directors and the advisory board for the Center for Healthcare Innovation, Healthcare
Charles holds an M.D. in Internal Medicine from the University of California at Los Angeles, an MBA in Corporate Strategy and Health Care Economics from Stanford University, and a Bachelor’s Degree in Genetics from the University of California at Berkeley.
Co-Founder, Managing Partner
Oded Levy is a Co-founder and a Managing Partner of Blue Ox and serves on the Investment Committee. He has over 30 years of experience in specialized healthcare investing in private equity, capital markets
He has served on multiple boards including former Blue Ox investments MedSave USA as Executive Chairman, Delphi Behavioral Health Group, LLC and Infinity Funding LLC.
Oded holds an MBA in Finance and International Business and a BS in Computer and Information Systems from New York University.
John A. Neczesny
Managing Partner, Chief Operating Officer
John Neczesny is a Managing Partner, serves on the Investment Committee, and is the Chief Operating Officer of Blue Ox. John has 20 years of experience transacting in the healthcare industry. Prior to Blue Ox, John was a Managing Director at Oberon Securities LLC, where he was an investment banker for growth-stage healthcare companies and special situations, and before that he was Vice President of Corporate Development at Par Pharmaceutical Companies. John began his career in finance in 1998 at Bear, Stearns & Co. Inc. and became a Managing Director in their Investment Banking Healthcare Group. During ten years there, John was involved in completing over 60 M&A and financing deals totaling $170B for biopharmaceutical, medical technology
John holds an MBA in Finance from New York University Stern School of Business and a BS in Chemistry from the University of Delaware.
Sheila H. Schweitzer
Co-Founder, Managing Partner
Sheila Schweitzer is a Co-founder and a Managing Partner of Blue Ox serving on the Investment Committee. Sheila has over 30 years of experience in the healthcare industry bringing
Sheila is a recognized expert in the healthcare industry and has testified before the US Congress and the Ministers of Health of the European Union on the topic of electronic transaction and claim processing. As an investor and executive, Sheila has been involved in over 40 deals totaling $3 billion.
Sheila served on the boards of Aventura, the leading provider of awareness computing, Recondo Health, and National Electronic Attachment and led its sale to KKR. Sheila was a founding member of WEDI, Workgroup for Electronic Data Interchange, and served on the ANSI X12 committee and participated in the development of the HIPAA legislation. She was Chairperson of AFEHCT, Association for Healthcare Electronic Transactions, and The Medical Banking Project and led the mergers of both with HIMSS. She has also held advisory roles with Aetna, Blue Cross and Blue Shield Association and NDC Health.
Sheila holds a BS in Chemistry from Western Kentucky University.
Alex R. Rogers
Alex Rogers is focused on investor relations and fund operations at Blue Ox and serves as a member of the investment team. Over the past 15 years, Alex has been a consultant, a limited partner, a general partner, and a service provider. Alex was an early part of the private markets consulting practice at NEPC and was involved in due diligence, portfolio construction, and investment monitoring for private equity clients. He was also a member of the Alternative Assets Investment Committee covering the healthcare, technology, and energy sectors. Alex was a member of the investor relations team at First Reserve, where he was also responsible for managing the co-investment program working with limited partners on direct investments. At Performance Equity Management, Alex led the launch of two funds. Prior to joining Blue Ox, Alex was a Senior Director at MVision Private Equity Advisors working with general partners to develop and market their funds.
Alex holds an MBA and BSBA in Finance from Northeastern University.
Mary G. Chelini
Mary G. Chelini is an analyst at Blue Ox, providing transaction support, communications